People · Operator
Named in public records as an officer, director or promoter · active 2020–2023 · Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| EyeRate Inc. | — | Other Technology | Series A | $4.6M | $44.3M | 2023 |
| Ariz Precision Medicine, Inc. | — | Pharmaceuticals | Pre-Seed | $685K | $32.4M | 2020 |
Sabya Das at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sabya Das on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Lokesh Sikaria | 1 | 6 |
| Kevin Nagle | 1 | 2 |
| Jacqui Deegan | 1 | 2 |
| Raymond Weisberg | 1 | 1 |
| Lonnie Bookbinder | 1 | 1 |
| Brad Niles | 1 | 1 |
| Michael Arrendondo | 1 | 1 |
| Mitchell Arrendondo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.